Metraipolis › archive › dc_ebda7dbb9f2d

Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US — Europe PMC PMID:41080929

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41080929
DOI: 10.3389/fmed.2025.1642279
License (as archived): solo-consultazione
Archived: 2026-11-09T17:52:13.164Z
SHA-256 of the archived text: faf05cbbd2f17816682f6ba39542c2d70660cd00de35130f24bfe7fc85053579
Stable URL of this page: https://metraipolis.com/documento/dc_ebda7dbb9f2d

How to cite

Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US — Europe PMC PMID:41080929 — Europe PMC (en), https://europepmc.org/article/MED/41080929 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebda7dbb9f2d (Metraipolis archive dc_ebda7dbb9f2d, sha256 faf05cbbd2f17816682f6ba39542c2d70660cd00de35130f24bfe7fc85053579)

BibTeX

@misc{dcebda7dbb9f2d,
  title = {Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US — Europe PMC PMID:41080929},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41080929},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebda7dbb9f2d; sha256 faf05cbbd2f17816682f6ba39542c2d70660cd00de35130f24bfe7fc85053579},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41080929. Agents can read the archived copy with the MCP tool read_document.